tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Werewolf Therapeutics Reports Q2 2025 Financial Results
PremiumCompany AnnouncementsWerewolf Therapeutics Reports Q2 2025 Financial Results
26d ago
Werewolf Therapeutics sees cash runway into 4Q26
Premium
The Fly
Werewolf Therapeutics sees cash runway into 4Q26
26d ago
Werewolf Therapeutics reports Q2 EPS (40c), consensus (37c)
Premium
The Fly
Werewolf Therapeutics reports Q2 EPS (40c), consensus (37c)
26d ago
Werewolf Therapeutics price target lowered to $6 from $8 at Wedbush
PremiumThe FlyWerewolf Therapeutics price target lowered to $6 from $8 at Wedbush
4M ago
Werewolf Therapeutics Reports Q1 2025 Financial Results
Premium
Company Announcements
Werewolf Therapeutics Reports Q1 2025 Financial Results
4M ago
Werewolf Therapeutics files $150M mixed securities shelf
Premium
The Fly
Werewolf Therapeutics files $150M mixed securities shelf
4M ago
Promising Investment in Werewolf Therapeutics: Strong Financials and Strategic Partnerships Drive Growth Prospects
PremiumRatingsPromising Investment in Werewolf Therapeutics: Strong Financials and Strategic Partnerships Drive Growth Prospects
6M ago
Unlocking Broader Therapeutic Potential: Andrew Fein’s Buy Rating on Werewolf Therapeutics
Premium
Ratings
Unlocking Broader Therapeutic Potential: Andrew Fein’s Buy Rating on Werewolf Therapeutics
6M ago
Werewolf Therapeutics Faces Geopolitical Risks Amid Changing Trade Policies with China
Premium
Company Announcements
Werewolf Therapeutics Faces Geopolitical Risks Amid Changing Trade Policies with China
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100